David J. Murphy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
David J. Murphy has a total of 172 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Sikora
University of Colorado School of Medicine, Department of Biomedical Informatics
12 shared publications - Susan Elizabeth Smith
University of Georgia College of Pharmacy Athens Georgia USA
12 shared publications - Brian Murray
University of Colorado Anschutz Medical Campus, Skaggs School of Pharmacy and Pharmaceutical Sciences. Department of Clinical Pharmacy, Aurora, CO, USA
11 shared publications - John W. Devlin
Department of Pharmacy and Health Systems Sciences, Bouve College of Health Sciences, Northeastern University, Boston, MA
9 shared publications - Xianyan Chen
University of Georgia College of Public Health, Department of Epidemiology & Biostatistics
9 shared publications - Rishikesan Kamaleswaran
Duke University
7 shared publications
Latest Publications
- Open Access
Impact of Early Interprofessional Involvement with a Critical Care Pharmacist on Patient Outcomes in the Intensive Care Unit
Background: While critical care pharmacists (CCPs) are broadly associated with improvements in outcomes for critically ill patients, operationalizing staffing in the intensive care unit (ICU) requires further study. The purpose of this evaluation was to determine the relationship of a CCP on interprofessional rounds for weekday admissions of ICU patients on patient-centered outcomes. Methods: This post-hoc analysis of the Optimizing Pharmacist-Team Integration for ICU Patient Management (OPTIM) study included adults admitted to an ICU on a weekday in the multicenter observational study. The primary outcome was in-hospital mortality. The primary exposure was level of comprehensive medication management (CMM) during the first 24 hours of ICU stay. A secondary exposure was pharmacist-to-patient ratio. Multivariable generalized estimating equations (GEE) were used to estimate associations between mortality and patient, ICU, and institution variables. Fine-Gray sub-distribution hazards regression estimated hazard of discharge alive (HDA) from the ICU and hospital and hazard of extubation alive. Results: 21,835 patients met inclusion criteria, and 76.1% of patients had CMM delivered on interprofessional rounds. Patients who had no CMM on the first ICU day had an increased risk of mortality of 23% (Odds Ratio (OR) 1.23, 95% Confidence Interval (CI) 1.04-1.46, p=0.02) compared to those who received CMM on interprofessional rounds. Patients with no CMM also had decreased HDA from the ICU and hospital and decreased hazard of extubation alive. No difference was seen in any outcomes when comparing other levels of CMM (CMM delivered outside of interprofessional rounds or abbreviated CMM) compared to CMM delivered on rounds. Conclusions: Absence of pharmacist CMM on the first day of ICU stay for patients with weekday admission was associated with an increased risk of in-hospital mortality, but no difference was seen across levels of CMM: this signal supports further investigation in prospective analysis. Key Points: Question: Do ICU patients who do not receive comprehensive medication management (CMM) from a critical care pharmacist (CCP) on interprofessional rounds on the first day have a relationship with worse outcomes? Finding: Patients not receiving CMM had increased mortality and length of stay, but no difference in outcomes was observed in patients receiving partial CMM or CMM delivered outside of interprofessional rounds. Meaning: CMM from a CCP is associated with improved patient outcomes compared to those not receiving CMM, but further research is needed to clarify optimal delivery of CMM and the impact of CCP participation on interprofessional rounds.
Open AccessImpact of Early Interprofessional Involvement with a Critical Care Pharmacist on Patient Outcomes in the Intensive Care Unit
Background: While critical care pharmacists (CCPs) are broadly associated with improvements in outcomes for critically ill patients, operationalizing staffing in the intensive care unit (ICU) requires further study. The purpose of this evaluation was to determine the relationship of a CCP on interprofessional rounds for weekday admissions of ICU patients on patient-centered outcomes. Methods: This post-hoc analysis of the Optimizing Pharmacist-Team Integration for ICU Patient Management (OPTIM) study included adults admitted to an ICU on a weekday in the multicenter observational study. The primary outcome was in-hospital mortality. The primary exposure was level of comprehensive medication management (CMM) during the first 24 hours of ICU stay. A secondary exposure was pharmacist-to-patient ratio. Multivariable generalized estimating equations (GEE) were used to estimate associations between mortality and patient, ICU, and institution variables. Fine-Gray sub-distribution hazards regression estimated hazard of discharge alive (HDA) from the ICU and hospital and hazard of extubation alive. Results: 21,835 patients met inclusion criteria, and 76.1% of patients had CMM delivered on interprofessional rounds. Patients who had no CMM on the first ICU day had an increased risk of mortality of 23% (Odds Ratio (OR) 1.23, 95% Confidence Interval (CI) 1.04-1.46, p=0.02) compared to those who received CMM on interprofessional rounds. Patients with no CMM also had decreased HDA from the ICU and hospital and decreased hazard of extubation alive. No difference was seen in any outcomes when comparing other levels of CMM (CMM delivered outside of interprofessional rounds or abbreviated CMM) compared to CMM delivered on rounds. Conclusions: Absence of pharmacist CMM on the first day of ICU stay for patients with weekday admission was associated with an increased risk of in-hospital mortality, but no difference was seen across levels of CMM: this signal supports further investigation in prospective analysis. Key Points: Question: Do ICU patients who do not receive comprehensive medication management (CMM) from a critical care pharmacist (CCP) on interprofessional rounds on the first day have a relationship with worse outcomes? Finding: Patients not receiving CMM had increased mortality and length of stay, but no difference in outcomes was observed in patients receiving partial CMM or CMM delivered outside of interprofessional rounds. Meaning: CMM from a CCP is associated with improved patient outcomes compared to those not receiving CMM, but further research is needed to clarify optimal delivery of CMM and the impact of CCP participation on interprofessional rounds.
- 10 July 2026
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 46 (8) , e70185
A Data‐Driven Medication Regimen Complexity Score for Critically Ill Patients: MRC ‐ ICU 2.0
Background: The 2019 medication regimen complexity‐intensive care unit (MRC‐ICU) score is associated with patient outcomes, ICU complications, and critical care pharmacist workload. This score was developed using heuristic component selection and validated in a single‐center cohort of 130 ICU patients. We sought to apply data‐driven reweighting methodology in a large, multicenter cohort of ICU adults to improve the predictive capabilities of MRC‐ICU. Methods: This was a retrospective, observational cohort study of adults admitted to an ICU between 2015 and 2023 at two academic health systems. Machine learning–based methods, including Principal Component Analysis and Random Forest, were used to create an updated MRC‐ICU score optimized to predict three outcomes: hospital mortality, ICU fluid overload (FO) occurrence, and invasive mechanical ventilation (IMV) use. MRC‐ICU 2.1 used average mortality, FO, and IMV use; MRC‐ICU 2.2 used average mortality and FO and adjusted for prolonged IMV use. Data from one center were used for training and testing, and data from the other for validation. The predictive abilities of MRC‐ICU 2.1 and 2.2 for each outcome were compared to MRC‐ICU 1.0 and to severity of illness scores (i.e., Acute Physiology and Chronic Health Evaluation [APACHE] II and Sequential Organ Failure Assessment [SOFA]). Results: A total of 19,117 patients across training, testing, and validation datasets were included. MRC‐ICU 2.0 scores outperformed MRC‐ICU 1.0 for predicting most outcomes, with improvements in Area Under the Receiver Operating Characteristic (AUROC) ranging from +0.03 to +0.08 across datasets. MRC‐ICU 2.1 and 2.2 did not consistently outperform APACHE II and SOFA in predicting mortality. The addition of MRC‐ICU 2.0 scores to models including APACHE II or SOFA resulted in statistically significant improvements in discrimination in several settings (DeLong p < 0.05), with AUROC increases generally ranging from approximately +0.01 to +0.13 depending on outcome and dataset. Conclusions: The updated MRC‐ICU 2.0 score (MRC‐ICU 2.1 and 2.2) demonstrated consistently improved discrimination compared with the original MRC‐ICU 1.0 across outcomes and datasets. The performance of MRC‐ICU 2.0 (MRC‐ICU 2.1 and 2.2) was generally comparable to established severity‐of‐illness scores (SOFA and APACHE II), although it did not consistently outperform these measures. When incorporated into combined models, MRC‐ICU 2.0 provided additional predictive value, indicating that it captures information complementary to traditional severity‐of‐illness scores. Overall, these findings suggest that MRC‐ICU 2.0 represents an improved and clinically interpretable measure of medication regimen complexity that is useful as a complementary predictor.
- 10 July 2026
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 46 (8) , e70185
A Data‐Driven Medication Regimen Complexity Score for Critically Ill Patients: MRC ‐ ICU 2.0
Background: The 2019 medication regimen complexity‐intensive care unit (MRC‐ICU) score is associated with patient outcomes, ICU complications, and critical care pharmacist workload. This score was developed using heuristic component selection and validated in a single‐center cohort of 130 ICU patients. We sought to apply data‐driven reweighting methodology in a large, multicenter cohort of ICU adults to improve the predictive capabilities of MRC‐ICU. Methods: This was a retrospective, observational cohort study of adults admitted to an ICU between 2015 and 2023 at two academic health systems. Machine learning–based methods, including Principal Component Analysis and Random Forest, were used to create an updated MRC‐ICU score optimized to predict three outcomes: hospital mortality, ICU fluid overload (FO) occurrence, and invasive mechanical ventilation (IMV) use. MRC‐ICU 2.1 used average mortality, FO, and IMV use; MRC‐ICU 2.2 used average mortality and FO and adjusted for prolonged IMV use. Data from one center were used for training and testing, and data from the other for validation. The predictive abilities of MRC‐ICU 2.1 and 2.2 for each outcome were compared to MRC‐ICU 1.0 and to severity of illness scores (i.e., Acute Physiology and Chronic Health Evaluation [APACHE] II and Sequential Organ Failure Assessment [SOFA]). Results: A total of 19,117 patients across training, testing, and validation datasets were included. MRC‐ICU 2.0 scores outperformed MRC‐ICU 1.0 for predicting most outcomes, with improvements in Area Under the Receiver Operating Characteristic (AUROC) ranging from +0.03 to +0.08 across datasets. MRC‐ICU 2.1 and 2.2 did not consistently outperform APACHE II and SOFA in predicting mortality. The addition of MRC‐ICU 2.0 scores to models including APACHE II or SOFA resulted in statistically significant improvements in discrimination in several settings (DeLong p < 0.05), with AUROC increases generally ranging from approximately +0.01 to +0.13 depending on outcome and dataset. Conclusions: The updated MRC‐ICU 2.0 score (MRC‐ICU 2.1 and 2.2) demonstrated consistently improved discrimination compared with the original MRC‐ICU 1.0 across outcomes and datasets. The performance of MRC‐ICU 2.0 (MRC‐ICU 2.1 and 2.2) was generally comparable to established severity‐of‐illness scores (SOFA and APACHE II), although it did not consistently outperform these measures. When incorporated into combined models, MRC‐ICU 2.0 provided additional predictive value, indicating that it captures information complementary to traditional severity‐of‐illness scores. Overall, these findings suggest that MRC‐ICU 2.0 represents an improved and clinically interpretable measure of medication regimen complexity that is useful as a complementary predictor.
- Open Access
- 25 June 2026
- Published by Elsevier in American Journal of Infection Control
- Vol. 54 (11) , 1176-1182
Qualitative analyses of contributing factors to central line-associated bloodstream infections and catheter-associated urinary tract infections during the COVID-19 pandemic
- 25 June 2026
- Published by Elsevier in American Journal of Infection Control
- Vol. 54 (11) , 1176-1182
Open AccessQualitative analyses of contributing factors to central line-associated bloodstream infections and catheter-associated urinary tract infections during the COVID-19 pandemic
- 23 January 2026
- Published by Elsevier in Critical Care Clinics
- Vol. 42 (2) , 397-413
Intensive Care Unit Quality Metrics
- 23 January 2026
- Published by Elsevier in Critical Care Clinics
- Vol. 42 (2) , 397-413
Intensive Care Unit Quality Metrics
- Open Access
Optimization of Pharmacist Medication Management and Mortality in the Intensive Care Unit
Rationale: Medication-related morbidity due to inappropriate prescribing, delays in appropriate treatment, and adverse drug events contributes to ICU patient mortality. Comprehensive medication management (CMM) is a care standard provided by pharmacists in collaboration with the interprofessional team. Optimizing ICU pharmacist workload via the pharmacist-to-patient ratio while ensuring daily CMM may reduce mortality. Research Question: Is ICU pharmacist staffing, measured by the pharmacist-to-patient ratio and absence of comprehensive medication management (CMM), associated with in-hospital mortality among critically ill adults? Study Design and Methods: Adults admitted to an ICU from 64 centers (in the United States, Jordan, and Saudi Arabia) were enrolled in a multicenter observational study that collected patient and team staffing data from August 2023-January 2025. The primary outcome was in-hospital mortality. The primary exposure was the patient-level pharmacist-to-patient ratio averaged over the ICU stay. A secondary exposure was the absence of CMM for at least 1 day. Multivariable generalized estimating equations (GEE) were used to estimate associations with in-hospital mortality, accounting for clustering by center and adjusting for patient-, ICU-, and hospital-level covariates. Results: The 28,795 patients enrolled had a median (IQR) pharmacist-to-patient ratio of 1:17 (13-23). For every one patient increase in the pharmacist-to-patient ratio, the odds of mortality increased by 1% (Odds Ratio (OR) 1.01, 95% Confidence Interval (CI) 1.00-1.01, p=0.04). Patients without pharmacist CMM for 1 day had an increased risk of mortality of 20% (OR 1.20, 95% CI 1.03-1.40, p=0.02). The odds of hospital mortality were lower in a pharmacist-to-patient ratio of 1:7-15 compared to 1:16-46 (OR 1.10, 95% CI 1.00-1.22). Interpretation: Increasing pharmacist-to-patient ratios and the absence of pharmacist CMM every day were both associated with an increased risk of in-hospital mortality.
Open AccessOptimization of Pharmacist Medication Management and Mortality in the Intensive Care Unit
Rationale: Medication-related morbidity due to inappropriate prescribing, delays in appropriate treatment, and adverse drug events contributes to ICU patient mortality. Comprehensive medication management (CMM) is a care standard provided by pharmacists in collaboration with the interprofessional team. Optimizing ICU pharmacist workload via the pharmacist-to-patient ratio while ensuring daily CMM may reduce mortality. Research Question: Is ICU pharmacist staffing, measured by the pharmacist-to-patient ratio and absence of comprehensive medication management (CMM), associated with in-hospital mortality among critically ill adults? Study Design and Methods: Adults admitted to an ICU from 64 centers (in the United States, Jordan, and Saudi Arabia) were enrolled in a multicenter observational study that collected patient and team staffing data from August 2023-January 2025. The primary outcome was in-hospital mortality. The primary exposure was the patient-level pharmacist-to-patient ratio averaged over the ICU stay. A secondary exposure was the absence of CMM for at least 1 day. Multivariable generalized estimating equations (GEE) were used to estimate associations with in-hospital mortality, accounting for clustering by center and adjusting for patient-, ICU-, and hospital-level covariates. Results: The 28,795 patients enrolled had a median (IQR) pharmacist-to-patient ratio of 1:17 (13-23). For every one patient increase in the pharmacist-to-patient ratio, the odds of mortality increased by 1% (Odds Ratio (OR) 1.01, 95% Confidence Interval (CI) 1.00-1.01, p=0.04). Patients without pharmacist CMM for 1 day had an increased risk of mortality of 20% (OR 1.20, 95% CI 1.03-1.40, p=0.02). The odds of hospital mortality were lower in a pharmacist-to-patient ratio of 1:7-15 compared to 1:16-46 (OR 1.10, 95% CI 1.00-1.22). Interpretation: Increasing pharmacist-to-patient ratios and the absence of pharmacist CMM every day were both associated with an increased risk of in-hospital mortality.
- Open Access
- 7 October 2025
- Published by Wolters Kluwer Health in Critical Care Explorations
- Vol. 7 (10) , e1331
Augmenting Mortality Prediction in Critically Ill Adults With Medication Data and Machine Learning Models
BACKGROUND: Mortality prediction in ICU adults is only marginally improved when medication regimen complexity (MRC) data is incorporated into traditional regression models. Machine learning (ML) may improve this prediction. OBJECTIVE: To compare the performance of different ML approaches incorporating MRC data to both traditional and advanced regression approaches, with and without MRC data, to predict hospital mortality in ICU adults. DERIVATION COHORT: Nine hundred ninety-one ICU adults at the University of North Carolina (UNC) Health System. VALIDATION COHORT: A temporally distinct cohort of 4,878 ICU adults at UNC and an external cohort of 12,290 ICU adults at the Oregon Health and Science University. PREDICTION MODEL: Supervised, classification-based ML models (e.g., Random Forest, Support Vector Machine [SVM], and XGBoost) were developed. Twenty-seven variables at ICU baseline (age, sex, service, diagnosis) and 24 hours (illness severity, supportive care use, fluid balance, laboratory values, MRC-ICU, vasopressor use) associated with mortality, and 14 missingness indicator variables, were included in each ML model. Traditional and advanced (equipped with linear predictors, predictors in nature cubic splines, predictors in smoothing cubic splines, and local linear predictors) regression models were optimized using stepwise selection by Bayesian Information Criterion. Area under the receiver operating characteristic (AUROC) was compared among models. RESULTS: Random Forest, SVM, and XGBoost achieved AUROCs of 0.83, 0.85, and 0.82, respectively, on the test set. Traditional regression models based on Sequential Organ Failure Assessment, Acute Physiology and Chronic Health Evaluation (APACHE) II, MRC-ICU + Sequential Organ Failure Assessment + APACHE II with and without an interaction term, and a full model including all 27 available variables demonstrated AUROCs of 0.81, 0.72, 0.82, 0.83, and 0.86, respectively. Advanced regression models yielded AUROCs of 0.85, 0.86, 0.85, and 0.84, respectively. The MRC-ICU exhibited a moderate level of feature importance in both XGBoost and Random Forest models. Models demonstrated lower performance in the validation cohorts. CONCLUSIONS: Use of ML, compared with traditional and advanced regression methods, did not improve hospital mortality prediction despite medication data inclusion. The MRC-ICU demonstrates moderate feature importance in select ML models.
- 7 October 2025
- Published by Wolters Kluwer Health in Critical Care Explorations
- Vol. 7 (10) , e1331
Open AccessAugmenting Mortality Prediction in Critically Ill Adults With Medication Data and Machine Learning Models
BACKGROUND: Mortality prediction in ICU adults is only marginally improved when medication regimen complexity (MRC) data is incorporated into traditional regression models. Machine learning (ML) may improve this prediction. OBJECTIVE: To compare the performance of different ML approaches incorporating MRC data to both traditional and advanced regression approaches, with and without MRC data, to predict hospital mortality in ICU adults. DERIVATION COHORT: Nine hundred ninety-one ICU adults at the University of North Carolina (UNC) Health System. VALIDATION COHORT: A temporally distinct cohort of 4,878 ICU adults at UNC and an external cohort of 12,290 ICU adults at the Oregon Health and Science University. PREDICTION MODEL: Supervised, classification-based ML models (e.g., Random Forest, Support Vector Machine [SVM], and XGBoost) were developed. Twenty-seven variables at ICU baseline (age, sex, service, diagnosis) and 24 hours (illness severity, supportive care use, fluid balance, laboratory values, MRC-ICU, vasopressor use) associated with mortality, and 14 missingness indicator variables, were included in each ML model. Traditional and advanced (equipped with linear predictors, predictors in nature cubic splines, predictors in smoothing cubic splines, and local linear predictors) regression models were optimized using stepwise selection by Bayesian Information Criterion. Area under the receiver operating characteristic (AUROC) was compared among models. RESULTS: Random Forest, SVM, and XGBoost achieved AUROCs of 0.83, 0.85, and 0.82, respectively, on the test set. Traditional regression models based on Sequential Organ Failure Assessment, Acute Physiology and Chronic Health Evaluation (APACHE) II, MRC-ICU + Sequential Organ Failure Assessment + APACHE II with and without an interaction term, and a full model including all 27 available variables demonstrated AUROCs of 0.81, 0.72, 0.82, 0.83, and 0.86, respectively. Advanced regression models yielded AUROCs of 0.85, 0.86, 0.85, and 0.84, respectively. The MRC-ICU exhibited a moderate level of feature importance in both XGBoost and Random Forest models. Models demonstrated lower performance in the validation cohorts. CONCLUSIONS: Use of ML, compared with traditional and advanced regression methods, did not improve hospital mortality prediction despite medication data inclusion. The MRC-ICU demonstrates moderate feature importance in select ML models.
- Top Cited PapersOpen Access
- 21 February 2025
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 53 (5) , e1045-e1054
Development of a Core Critical Care Data Dictionary With Common Data Elements to Characterize Critical Illness and Injuries Using a Modified Delphi Method
OBJECTIVES: To develop the first core Critical Care Data Dictionary (C2D2) with common data elements (CDEs) to characterize critical illness and injuries. DESIGN: Group consensus process using modified Delphi approach. SETTING: Electronic surveys and in-person meetings. SUBJECTS: A multidisciplinary workgroup of clinicians and researchers with expertise in the care of the critically ill and injured. INTERVENTIONS: The Delphi process was divided into domain and CDE portions with each composed of two item generation rounds and one item reduction/refinement rounds. Two in-person meetings augmented this process to facilitate review and consideration of the domains and by panel members. The final set of domains and CDEs was then reviewed by the group to meet the competing criteria of utility and feasibility, resulting in the core dataset. MEASUREMENTS AND MAIN RESULTS: The 23-member Delphi panel was provided 1833 candidate variables for potential dataset inclusion. The final dataset includes 226 patient-level CDCs in nine domains, which include anthropometrics and demographics (8), chronic comorbid illnesses (18), advanced directives (1), ICU diagnoses (61), diagnostic tests (42), interventions (27), medications (38), objective assessments (26), and hospital course and outcomes (5). Upon final review, 91% of the panel endorsed the CDCs as meeting criteria for a minimum viable data dictionary. Data elements cross the lifespan of neonate through adult patients. CONCLUSIONS: The resulting C2D2 provides a foundation to facilitate rapid collection, analyses, and dissemination of information necessary for research, quality improvement, and clinical practice to optimize critical care outcomes. Further work is needed to validate the effectiveness of the dataset in a variety of critical care settings.
- 21 February 2025
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 53 (5) , e1045-e1054
Top Cited PapersOpen AccessDevelopment of a Core Critical Care Data Dictionary With Common Data Elements to Characterize Critical Illness and Injuries Using a Modified Delphi Method
OBJECTIVES: To develop the first core Critical Care Data Dictionary (C2D2) with common data elements (CDEs) to characterize critical illness and injuries. DESIGN: Group consensus process using modified Delphi approach. SETTING: Electronic surveys and in-person meetings. SUBJECTS: A multidisciplinary workgroup of clinicians and researchers with expertise in the care of the critically ill and injured. INTERVENTIONS: The Delphi process was divided into domain and CDE portions with each composed of two item generation rounds and one item reduction/refinement rounds. Two in-person meetings augmented this process to facilitate review and consideration of the domains and by panel members. The final set of domains and CDEs was then reviewed by the group to meet the competing criteria of utility and feasibility, resulting in the core dataset. MEASUREMENTS AND MAIN RESULTS: The 23-member Delphi panel was provided 1833 candidate variables for potential dataset inclusion. The final dataset includes 226 patient-level CDCs in nine domains, which include anthropometrics and demographics (8), chronic comorbid illnesses (18), advanced directives (1), ICU diagnoses (61), diagnostic tests (42), interventions (27), medications (38), objective assessments (26), and hospital course and outcomes (5). Upon final review, 91% of the panel endorsed the CDCs as meeting criteria for a minimum viable data dictionary. Data elements cross the lifespan of neonate through adult patients. CONCLUSIONS: The resulting C2D2 provides a foundation to facilitate rapid collection, analyses, and dissemination of information necessary for research, quality improvement, and clinical practice to optimize critical care outcomes. Further work is needed to validate the effectiveness of the dataset in a variety of critical care settings.
- 3 January 2025
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 45 (2) , 76-86
Unsupervised machine learning analysis to identify patterns of ICU medication use for fluid overload prediction
Background: Fluid overload (FO) in the intensive care unit (ICU) is common, serious, and may be preventable. Intravenous medications (including administered volume) are a primary cause for FO but are challenging to evaluate as a FO predictor given the high frequency and time‐dependency of their use and other factors affecting FO. We sought to employ unsupervised machine learning methods to uncover medication administration patterns correlating with FO.Methods: This retrospective cohort study included 927 adults admitted to an ICU for ≥72 h. FO was defined as a positive fluid balance ≥7% of admission body weight. After reviewing medication administration record data in 3‐h periods, medication exposure was categorized into clusters using principal component analysis (PCA) and Restricted Boltzmann Machine (RBM). Medication regimens of patients with and without FO were compared within clusters to assess their temporal association with FO.Results: FO occurred in 127 (13.7%) of 927 included patients. Patients received a median (interquartile range) of 31(13–65) discrete intravenous medication administrations over the 72‐h period. Across all 47,803 intravenous medication administrations, 10 unique medication clusters, containing 121 to 130 medications per cluster, were identified. The mean number of Cluster 7 medications administered was significantly greater in the FO cohort compared with patients without FO (25.6 vs.10.9, p < 0.0001). A total of 51 (40.2%) of 127 unique Cluster 7 medications were administered in more than five different 3‐h periods during the 72‐h study window. The most common Cluster 7 medications included continuous infusions, antibiotics, and sedatives/analgesics. Addition of Cluster 7 medications to an FO prediction model including the Acute Physiologic and Chronic Health Evaluation (APACHE) II score and receipt of diuretics improved model predictiveness from an Area Under the Receiver Operation Characteristic (AUROC) curve of 0.719 to 0.741 (p = 0.027).Conclusions: Using machine learning approaches, a unique medication cluster was strongly associated with FO. Incorporation of this cluster improved the ability to predict FO compared to traditional prediction models. Integration of this approach into real‐time clinical applications may improve early detection of FO to facilitate timely intervention.
- 3 January 2025
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 45 (2) , 76-86
Unsupervised machine learning analysis to identify patterns of ICU medication use for fluid overload prediction
Background: Fluid overload (FO) in the intensive care unit (ICU) is common, serious, and may be preventable. Intravenous medications (including administered volume) are a primary cause for FO but are challenging to evaluate as a FO predictor given the high frequency and time‐dependency of their use and other factors affecting FO. We sought to employ unsupervised machine learning methods to uncover medication administration patterns correlating with FO.Methods: This retrospective cohort study included 927 adults admitted to an ICU for ≥72 h. FO was defined as a positive fluid balance ≥7% of admission body weight. After reviewing medication administration record data in 3‐h periods, medication exposure was categorized into clusters using principal component analysis (PCA) and Restricted Boltzmann Machine (RBM). Medication regimens of patients with and without FO were compared within clusters to assess their temporal association with FO.Results: FO occurred in 127 (13.7%) of 927 included patients. Patients received a median (interquartile range) of 31(13–65) discrete intravenous medication administrations over the 72‐h period. Across all 47,803 intravenous medication administrations, 10 unique medication clusters, containing 121 to 130 medications per cluster, were identified. The mean number of Cluster 7 medications administered was significantly greater in the FO cohort compared with patients without FO (25.6 vs.10.9, p < 0.0001). A total of 51 (40.2%) of 127 unique Cluster 7 medications were administered in more than five different 3‐h periods during the 72‐h study window. The most common Cluster 7 medications included continuous infusions, antibiotics, and sedatives/analgesics. Addition of Cluster 7 medications to an FO prediction model including the Acute Physiologic and Chronic Health Evaluation (APACHE) II score and receipt of diuretics improved model predictiveness from an Area Under the Receiver Operation Characteristic (AUROC) curve of 0.719 to 0.741 (p = 0.027).Conclusions: Using machine learning approaches, a unique medication cluster was strongly associated with FO. Incorporation of this cluster improved the ability to predict FO compared to traditional prediction models. Integration of this approach into real‐time clinical applications may improve early detection of FO to facilitate timely intervention.
- Open Access
Effect of comprehensive medication management on mortality in critically ill patients
Background: Medication management in the intensive care unit (ICU) is causally linked to both treatment success and potential adverse drug events (ADEs), often associated with deleterious consequences. Patients with higher severity of illness tend to require more management. The purpose of this evaluation was to explore the effect of comprehensive medication management (CMM) on mortality in critically ill patients. Methods: In this retrospective cohort study of adult ICU patients, CMM was measured by critical care pharmacist (CCP) medication interventions. Propensity score matching was performed to generate a balanced 1:1 matched cohort, and logistic regression was applied for estimating propensity scores. The primary outcome was the odds of hospital mortality. Hospital and ICU length of stay were also assessed. Results: In a cohort of 10,441 ICU patients, the unadjusted mortality rate was 11% with a mean APACHE II score of 9.54 ± 4.18 and Medication Regimen Complexity-Intensive Care Unit (MRC-ICU) score of 5.78 ± 4.09. Compared with CCP interventions less than 3, more CCP interventions was associated with a significantly reduced risk of mortality (estimate -0.04, 95% confidence interval -0.06 - -0.03, p < 0.01) and shorter length of ICU stay (estimate -2.77, 95% CI -2.98 - - 2.56, p < 0.01). Conclusions: The degree by which CCPs deliver CMM in the ICU is directly associated with reduced hospital mortality independent of patient characteristics and medication regimen complexity.
Open AccessEffect of comprehensive medication management on mortality in critically ill patients
Background: Medication management in the intensive care unit (ICU) is causally linked to both treatment success and potential adverse drug events (ADEs), often associated with deleterious consequences. Patients with higher severity of illness tend to require more management. The purpose of this evaluation was to explore the effect of comprehensive medication management (CMM) on mortality in critically ill patients. Methods: In this retrospective cohort study of adult ICU patients, CMM was measured by critical care pharmacist (CCP) medication interventions. Propensity score matching was performed to generate a balanced 1:1 matched cohort, and logistic regression was applied for estimating propensity scores. The primary outcome was the odds of hospital mortality. Hospital and ICU length of stay were also assessed. Results: In a cohort of 10,441 ICU patients, the unadjusted mortality rate was 11% with a mean APACHE II score of 9.54 ± 4.18 and Medication Regimen Complexity-Intensive Care Unit (MRC-ICU) score of 5.78 ± 4.09. Compared with CCP interventions less than 3, more CCP interventions was associated with a significantly reduced risk of mortality (estimate -0.04, 95% confidence interval -0.06 - -0.03, p < 0.01) and shorter length of ICU stay (estimate -2.77, 95% CI -2.98 - - 2.56, p < 0.01). Conclusions: The degree by which CCPs deliver CMM in the ICU is directly associated with reduced hospital mortality independent of patient characteristics and medication regimen complexity.